VERFAHREN ZUM NACHWEIS VON HELICOBACTER PYLORI UND HEILMANII
    1.
    发明授权
    VERFAHREN ZUM NACHWEIS VON HELICOBACTER PYLORI UND HEILMANII 有权
    检测方法的幽门螺杆菌与heilmanii的

    公开(公告)号:EP1257823B1

    公开(公告)日:2004-02-04

    申请号:EP01919280.6

    申请日:2001-02-14

    IPC分类号: G01N33/569

    摘要: The invention relates to a method for detecting pathogenic organisms, especially Helicobacter pylori and H. heilmanii , in fecal, salivary and secretion specimen by a double antibody sandwich assay. The inventive method is characterized by dissolving or dispersing the specimen together with a pathogenic antigen in a buffer solution and contacting the buffer solution with a solid phase to which at least two primary antibodies are bound, one of which specifically binds to the pathogenic antigen and the other to human immunoglobulin A; washing the solid phase of non-specifically bound proteins and contacting the solid phase with a secondary antibody that specifically binds to the pathogenic antigen; and determining the amount of specifically bound secondary antibody.

    VERFAHREN ZUM NACHWEIS VON HELICOBACTER PYLORI UND HEILMANII
    2.
    发明公开
    VERFAHREN ZUM NACHWEIS VON HELICOBACTER PYLORI UND HEILMANII 有权
    检测方法的幽门螺杆菌与heilmanii的

    公开(公告)号:EP1257823A2

    公开(公告)日:2002-11-20

    申请号:EP01919280.6

    申请日:2001-02-14

    IPC分类号: G01N33/569

    摘要: The invention relates to a method for detecting pathogenic organisms, especially Helicobacter pylori and H. heilmanii, in fecal, salivary and secretion specimen by a double antibody sandwich assay. The inventive method is characterized by dissolving or dispersing the specimen together with a pathogenic antigen in a buffer solution and contacting the buffer solution with a solid phase to which at least two primary antibodies are bound, one of which specifically binds to the pathogenic antigen and the other to human immunoglobulin A; washing the solid phase of non-specifically bound proteins and contacting the solid phase with a secondary antibody that specifically binds to the pathogenic antigen; and determining the amount of specifically bound secondary antibody.